We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAN:BMEBanco Santander, S.A. Analysis

Data as of 2026-06-03 - not real-time

$12.16

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Banco Santander (SAN) is trading at $12.16, just below its 20‑day SMA of $12.19 but comfortably above the 50‑day SMA of $11.98, indicating a modest bullish bias from the medium‑term trend perspective. The RSI of 49.8 sits at the neutral midpoint while the MACD line (+0.101) sits above its signal (+0.094) with a positive histogram (+0.007), reinforcing a gentle bullish momentum. Volume is on an increasing trend and the 30‑day volatility is elevated at 32.7%, which together with a beta of roughly 1.7 and a max drawdown of –20.3% points to a higher systematic risk profile. Fundamentally, the stock appears undervalued – its trailing P/E of 11.8 is well below the industry average of 16.4 and the forward P/E of 9.3 suggests further upside, while the price‑to‑book of 1.49 and dividend yield of 2.24% with a low payout ratio (≈25% of earnings) support dividend sustainability. Operating margins are solid (43% operating, 34% profit) and revenue is growing modestly (4.6% YoY), yet cash flow generation is weak (negative operating cash flow and zero free cash flow), which tempers the optimism. Overall, the stock presents a blend of value and growth characteristics, with a slight bias toward buying on the back of strong earnings quality, attractive yield, and an undervalued valuation, but investors should remain mindful of the elevated price volatility and systematic risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • price just above 50‑day SMA indicating short‑term upside
  • bullish MACD histogram and signal crossover
  • increasing volume supporting momentum

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • undervalued P/E relative to industry peers
  • solid operating and profit margins
  • sustainable dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • strong earnings growth and forward EPS acceleration
  • attractive valuation gap versus sector average
  • stable dividend and capital adequacy (CET1 ratio at all‑time high)

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin34.10%
P/E Ratio11.8
ROE12.89%
ROA0.78%
P/B Ratio1.5
Op. Cash Flow$-15418000384
Industry P/E16.4

Technical Analysis

TrendBullish
RSI49.8
Support$11.65
Resistance$12.72
MA 20$12.19
MA 50$11.98
MA 200$11.23
MACDBullish
VolumeIncreasing
Fear & Greed Index92.75

Valuation

Target Price$12.16
Upside/Downside-0.03%
GradeUndervalued
TypeBlend
Dividend Yield2.24%

Risk Assessment

Beta1.69
Volatility32.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.